Medscape covers a new international consensus statement on how GLP-1 receptor agonists should be handled around pregnancy.
Recap by typeshit. Full story at Medscape.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Exposures nearly doubled from 460 the quarter before, and the FDA got two death reports it hasn't verified. Lilly says it has referred over 200 sellers to regulators.
The 80-week Lancet study enrolled 1,152 adults. Placebo lost 5.1%, and nearly half on the 12 mg dose lost at least 20%. The drug is still investigational.
Loading…